| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 9564 | 2021 |
| 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ... Polish Heart Journal (Kardiologia Polska) 73 (12), 1207-1294, 2015 | 7972 | 2015 |
| 2016 ESC/EAS guidelines for the management of dyslipidaemias AL Catapano, I Graham, G De Backer, O Wiklund, MJ Chapman, H Drexel, ... Polish Heart Journal (Kardiologia Polska) 74 (11), 1234-1318, 2016 | 4635 | 2016 |
| 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and … F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ... European heart journal 41 (2), 255-323, 2020 | 4386 | 2020 |
| European Society of Cardiology: cardiovascular disease statistics 2019 A Timmis, N Townsend, CP Gale, A Torbica, M Lettino, SE Petersen, ... European heart journal 41 (1), 12-85, 2020 | 2568 | 2020 |
| EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries K Kotseva, D Wood, D De Bacquer, G De Backer, L Rydén, C Jennings, ... European journal of preventive cardiology 23 (6), 636-648, 2016 | 1300 | 2016 |
| Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo … PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ... The Lancet 390 (10105), 1833-1842, 2017 | 1170 | 2017 |
| Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries P Widimsky, W Wijns, J Fajadet, M De Belder, J Knot, L Aaberge, ... European heart journal 31 (8), 943-957, 2010 | 1039 | 2010 |
| Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled … PM Ridker, JG MacFadyen, BM Everett, P Libby, T Thuren, RJ Glynn, ... The Lancet 391 (10118), 319-328, 2018 | 804 | 2018 |
| Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry K Kotseva, G De Backer, D De Bacquer, L Rydén, A Hoes, D Grobbee, ... European journal of preventive cardiology 26 (8), 824-835, 2019 | 798 | 2019 |
| Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology MG Crespo‐Leiro, M Metra, LH Lund, D Milicic, MR Costanzo, ... European journal of heart failure 20 (11), 1505-1535, 2018 | 797 | 2018 |
| Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association … PM Seferovic, P Ponikowski, SD Anker, J Bauersachs, O Chioncel, ... European journal of heart failure 21 (10), 1169-1186, 2019 | 723 | 2019 |
| Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial P Ponikowski, BA Kirwan, SD Anker, T McDonagh, M Dorobantu, ... The Lancet 396 (10266), 1895-1904, 2020 | 577 | 2020 |
| Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries SD Kristensen, KG Laut, J Fajadet, Z Kaifoszova, P Kala, C Di Mario, ... European heart journal 35 (29), 1957-1970, 2014 | 492 | 2014 |
| 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European Heart Journal 44 (37), 3627-3639, 2023 | 427 | 2023 |
| Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation V Vaccarino, L Badimon, JD Bremner, E Cenko, J Cubedo, M Dorobantu, ... European heart journal 41 (17), 1687-1696, 2020 | 350* | 2020 |
| The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2 MV Huisman, KJ Rothman, M Paquette, C Teutsch, HC Diener, SJ Dubner, ... Journal of the American College of Cardiology 69 (7), 777-785, 2017 | 338 | 2017 |
| Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology PM Seferović, M Polovina, J Bauersachs, M Arad, T Ben Gal, LH Lund, ... European journal of heart failure 21 (5), 553-576, 2019 | 333 | 2019 |
| Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ... Atherosclerosis 285, 135-146, 2019 | 304 | 2019 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 249 | 2019 |
